Products

What will AGI do for Alvimopan anhydrous?

This classification denotes the anhydrous form of an opiate antagonist with the molecular formula C25H32N2O4.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 677C126AET, chemically known as glycine, n-((2s)-2-(((3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-, dihydrate but more generally known as alvimopan, which bears US NIH Compound Identifier 5488547. Alvimopan most often comes in simple, anhydrous, and hyrdate forms. European Medicines Agency schedules Alvimopan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20585. World Health Organization schedules alvimopan in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule alvimopan anhydrous under HS 29333999. As of Q4 2014, ALVIMOPAN ANHYDROUS remains US FDA's Preferred Term for this commodity. Alvimopan anhydrous bears US NLM identifiers UMLS ID C2698078 and NCI Concept Code C77377. SMILES: C[C@H]1CN(CC[C@@]1(C)C2CCCC(C2)O)C[C@H](CC3CCCCC3)C(=O)NCC(=O)O.